SciELO - Scientific Electronic Library Online

vol.72 issue2Pretemporal craniotomyNutritional care in motor neurone disease/ amyotrophic lateral sclerosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X


BRUM, Doralina Guimarães; COMINI-FROTA, Elizabeth Regina; VASCONCELOS, Claúdia Cristina F.  and  DIAS-TOSTA, Elza. Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: Consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology. Arq. Neuro-Psiquiatr. [online]. 2014, vol.72, n.2, pp.152-156. ISSN 0004-282X.

Multiple sclerosis (MS) is an inflammatory, autoimmune, demyelinating, and degenerative central nervous system disease. Even though the etiology of MS has not yet been fully elucidated, there is evidence that genetic and environmental factors interact to cause the disease. Among the main environmental factors studied, those more likely associated with MS include certain viruses, smoking, and hypovitaminosis D. This review aimed to determine whether there is evidence to recommend the use of vitamin D as monotherapy or as adjunct therapy in patients with MS. We searched PUBMED, EMBASE, COCHRANNE, and LILACS databases for studies published until September 9 th , 2013, using the keywords “multiple sclerosis”, “vitamin D”, and “clinical trial”. There is no scientific evidence up to the production of this consensus for the use of vitamin D as monotherapy for MS in clinical practice.

Keywords : vitamin D; multiple sclerosis; experimental autoimmune encephalitis.

        · abstract in Portuguese     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )